Jian-sheng Han

A chemical tuned strategy to develop novel irreversible EGFR-TK inhibitors with improved safety and pharmacokinetic profiles.

Wei Huang, Wenteng Chen, Jing-kang Shen, 2014, Journal of medicinal chemistry.